comparemela.com

Latest Breaking News On - Bloom burton - Page 1 : comparemela.com

Repare Therapeutics (NASDAQ:RPTX) Rating Reiterated by HC Wainwright

Repare Therapeutics (NASDAQ:RPTX – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research report issued on Thursday, Benzinga reports. They presently have a $10.00 target price on the stock. HC Wainwright’s price target would indicate a potential upside of 187.36% from the stock’s previous close. Separately, […]

Canada
United-states
Repare-therapeutics-inc
Exchange-traded-concepts
Harbor-capital-advisors-inc
Repare-therapeutics-company-profile
Connor-clark-lunn-investment-management-ltd
Blackstone-inc
Raymond-james-financial-services-advisors-inc
Repare-therapeutics
Get-free-report

Bloom Burton Comments on AbCellera Biologics Inc.'s FY2026 Earnings (NASDAQ:ABCL)

Bloom Burton Comments on AbCellera Biologics Inc.'s FY2026 Earnings (NASDAQ:ABCL)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Abcellera-biologics
Stifel-nicolaus
Abcellera-biologics-company-profile
Capital-partners
Schonfeld-strategic-advisors
Abcellera-biologics-inc
Keycorp
Nasdaq
B-riley-wealth-advisors-inc
Free-report
Bloom-burton
Abcellera-biologic

Investing in R&D-Stage Healthcare Companies: A Recap of BBHIC 2024

It was another record-breaking year for the annual Bloom Burton & Co. Healthcare Investor Conference BBHIC in Toronto. The event brought together premier healthcare companies and investors from Canada and around the world.

Toronto
Ontario
Canada
China
United-states
Chinese
American
Bennett-jone
Kim-lawton
Aaron-sonshine
Pharma-lifesciences
Bloom-burton-co

Repare Therapeutics (NASDAQ:RPTX) Rating Increased to Buy at Bloom Burton

Bloom Burton upgraded shares of Repare Therapeutics (NASDAQ:RPTX – Free Report) from an accumulate rating to a buy rating in a research note issued to investors on Friday morning, Zacks.com reports. Separately, HC Wainwright reissued a buy rating and issued a $10.00 price objective on shares of Repare Therapeutics in a research note on Wednesday, […]

United-states
Canada
Investment-management
Raymond-james-financial-services-advisors-inc
Vontobel-holding-ltd
Jump-financial
Repare-therapeutics-inc
Bloom-burton
Repare-therapeutics
Free-report
Get-free-report

vimarsana © 2020. All Rights Reserved.